306 related articles for article (PubMed ID: 35648593)
1. Synthetic Strategies for Rare Cannabinoids Derived from
Nguyen GN; Jordan EN; Kayser O
J Nat Prod; 2022 Jun; 85(6):1555-1568. PubMed ID: 35648593
[TBL] [Abstract][Full Text] [Related]
2. [Determination of 11 Cannabinoids in Cannabis sativa L. by Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-Q-TOF-MS)].
Tanaka R; Mizutani S; Kawamura M; Fuchino H; Kawahara N; Kikura-Hanajiri R
Yakugaku Zasshi; 2023; 143(4):411-418. PubMed ID: 37005243
[TBL] [Abstract][Full Text] [Related]
3. Selective Extraction of Cannabinoid Compounds from Cannabis Seed Using Pressurized Hot Water Extraction.
Nuapia Y; Tutu H; Chimuka L; Cukrowska E
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183432
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.
Fischedick J; Van Der Kooy F; Verpoorte R
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):201-7. PubMed ID: 20118579
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a GC-FID Method for the Quantitation of 20 Different Acidic and Neutral Cannabinoids.
Gul W; Ibrahim EA; Gul SW; Shahzadi I; Radwan MM; Chandra S; Lata H; ElSohly MA
Planta Med; 2023 May; 89(6):683-696. PubMed ID: 36257598
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.
Wiley JL; Marusich JA; Blough BE; Namjoshi O; Brackeen M; Akinfiresoye LR; Walker TD; Prioleau C; Barrus DG; Gamage TF
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jun; 132():110984. PubMed ID: 38417478
[TBL] [Abstract][Full Text] [Related]
7. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
Fernández N; Cappello MG; Quiroga PN
Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
[TBL] [Abstract][Full Text] [Related]
8. Determination of cannabinoids in human cerumen samples by use of UPLC-MS/MS as a potential biomarker for drug use.
Christodoulou MC; Constantinou MS; Louppis AP; Christou A; Stavrou IJ; Kapnissi-Christodoulou CP
J Pharm Biomed Anal; 2023 Jul; 231():115412. PubMed ID: 37087774
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of CBD, Δ
Jaidee W; Siridechakorn I; Nessopa S; Wisuitiprot V; Chaiwangrach N; Ingkaninan K; Waranuch N
Cannabis Cannabinoid Res; 2022 Aug; 7(4):537-547. PubMed ID: 34096805
[No Abstract] [Full Text] [Related]
10. Direct Quantitation of Phytocannabinoids by One-Dimensional
Dadiotis E; Mitsis V; Melliou E; Magiatis P
Molecules; 2022 May; 27(9):. PubMed ID: 35566314
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
El-Alfy AT; Ivey K; Robinson K; Ahmed S; Radwan M; Slade D; Khan I; ElSohly M; Ross S
Pharmacol Biochem Behav; 2010 Jun; 95(4):434-42. PubMed ID: 20332000
[TBL] [Abstract][Full Text] [Related]
12. Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study.
Krämer M; Schäper M; Dücker K; Philipsen A; Losacker M; Dreimüller N; Engelmann J; Madea B; Hess C
Drug Test Anal; 2021 Sep; 13(9):1614-1626. PubMed ID: 34114750
[TBL] [Abstract][Full Text] [Related]
13. Isolation and Characterization of Impurities in Commercially Marketed Δ
Radwan MM; Wanas AS; Gul W; Ibrahim EA; ElSohly MA
J Nat Prod; 2023 Apr; 86(4):822-829. PubMed ID: 36827690
[TBL] [Abstract][Full Text] [Related]
14. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
[TBL] [Abstract][Full Text] [Related]
15. Determination of 11 Cannabinoids in Biomass and Extracts of Different Varieties of Cannabis Using High-Performance Liquid Chromatography.
Gul W; Gul SW; Radwan MM; Wanas AS; Mehmedic Z; Khan II; Sharaf MH; ElSohly MA
J AOAC Int; 2015; 98(6):1523-8. PubMed ID: 26651563
[TBL] [Abstract][Full Text] [Related]
16. ¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification.
Peschel W; Politi M
Talanta; 2015 Aug; 140():150-165. PubMed ID: 26048837
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions.
Nasrin S; Watson CJW; Perez-Paramo YX; Lazarus P
Drug Metab Dispos; 2021 Dec; 49(12):1070-1080. PubMed ID: 34493602
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the cataleptic effect of tetrahydrocannabinol by other constituents of Cannabis sativa L.
Formukong EA; Evans AT; Evans FJ
J Pharm Pharmacol; 1988 Feb; 40(2):132-4. PubMed ID: 2897447
[TBL] [Abstract][Full Text] [Related]
19. Extensive phytocannabinoid profiles of seized cannabis and cannabis-based medicines - Identification of potential distinguishing markers.
Scheunemann A; Elsner K; Germerott T; Hess C; Zörntlein S; Röhrich J
Forensic Sci Int; 2021 May; 322():110773. PubMed ID: 33839545
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile.
Swift W; Wong A; Li KM; Arnold JC; McGregor IS
PLoS One; 2013; 8(7):e70052. PubMed ID: 23894589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
